Sviripa Vitaliy M, Zhang Wen, Kril Liliia M, Liu Alice X, Yuan Yaxia, Zhan Chang-Guo, Liu Chunming, Watt David S
Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, United States; Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, United States.
Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, United States; Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0093, United States.
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3638-40. doi: 10.1016/j.bmcl.2014.04.113. Epub 2014 May 9.
Halogenated diarylacetylenes that possess fluorine or chlorine substituents in one aryl ring and N-methylamino or N,N-dimethylamino in the other aryl ring inhibit the proliferation of LS174T colon cancer cells through the repression of c-myc expression and induction of the cyclin-dependent kinase inhibitor-1 (i.e., p21(Wif1/Cip1)) and represent potentially useful antineoplastic agents.
在一个芳基环中具有氟或氯取代基且在另一个芳基环中具有N-甲基氨基或N,N-二甲基氨基的卤代二芳基乙炔通过抑制c-myc表达和诱导细胞周期蛋白依赖性激酶抑制剂-1(即p21(Wif1/Cip1))来抑制LS174T结肠癌细胞的增殖,是潜在有用的抗肿瘤药物。